Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Brooke

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The New England Journal of Medicine|October 21, 2011
Inflammatory skin and bowel disease linked to ADAM17 deletionDiana C Blaydon, Paolo Biancheri, Wei-Li Di, et al.
Science Signaling|November 5, 2015
Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17Sathish K Maney, David R McIlwain, Robin Polz, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The New England Journal of Medicine|October 21, 2011
Inflammatory skin and bowel disease linked to ADAM17 deletionDiana C Blaydon, Paolo Biancheri, Wei-Li Di, et al.
Science Signaling|November 5, 2015
Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17Sathish K Maney, David R McIlwain, Robin Polz, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Pageof 2